InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,263.60
(
0.02%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
84.88
(
-0.15%
)
Bitcoin
63,678.95
(
-1.76%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119885
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 62161

Wednesday, 04/30/2008 11:56:13 PM

Wednesday, April 30, 2008 11:56:13 PM

Post# of 252279
MNTA – The following is obvious, but perhaps it ought to stated anyhow in light of drbio’s post:

If MNTA/Sandoz’s Lovenox is approved and Teva’s and Amphastar’s are not, MNTA/Sandoz’s Lovenox will be the largest-selling generic drug in history by a wide margin.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up